Table 2.
Procedural details.
| Remote MI | ARVC | NI-DCM | P value | |
|---|---|---|---|---|
| Clinical VTCL (ms) | 375±80† | 334±63⁎ | 431±88⁎† | <0.01⁎ |
| <0.05† | ||||
| Induced VT (n) | 2.2±1.6 | 2.4±1.5 | 2.1±1.1 | NS |
| Clinical VT induction (%) | 40 (78) | 17 (94) | 13 (68) | NS |
| Irrigation system usage (%) | 27 (53) | 7 (39) | 13 (68) | NS |
| Mapping method | ||||
| VT mapping | VT: 18† | VT: 9† | VT: 13† | <0.05† |
| Substrate mapping | SU: 41⁎ | SU: 13⁎ | SU: 13⁎ | NS⁎ |
| Acute success (%) | 49 (96) | 14 (78) | 19 (100) | <0.05 |
| Inducibility of nonclinical, hemodynamically unstable VT (%) | 19 (37) | 8 (44) | 7 (37) | NS |
| Failure | 2 (4) | 4 (22) | 0 (0) | <0.05 |
| Epicardial approach | 4 | 2 | 9 | <0.01 |
CL=cycle length; SU=substrate mapping; VT=VT mapping.
Data are presented as the mean±SD or n (%).